XML 22 R10.htm IDEA: XBRL DOCUMENT v3.25.1
Fair Value Measurements
3 Months Ended
Mar. 31, 2025
Fair Value Measurements  
Fair Value Measurements

3.Fair Value Measurements

The following table presents information about the Company’s assets and liabilities that are regularly measured and carried at fair value and indicate the level within the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value (in thousands):

As of March 31, 2025

Description

    

Total Carrying Value

Quoted Prices in Active Market
(Level 1)

    

Significant Other Observable Inputs
(Level 2)

    

Significant Other Observable Inputs
(Level 3)

Assets:

Cash

$

23,721

$

23,721

$

$

Money market funds

172,833

172,833

Short-term investments:

Commercial paper

6,387

6,387

Corporate debt securities

45,418

45,418

Government securities

64,020

64,020

Long-term investments:

Corporate debt securities

1,835

1,835

Total assets

$

314,214

$

260,574

$

53,640

$

As of December 31, 2024

Description

    

Total Carrying Value

Quoted Prices in Active Market
(Level 1)

    

Significant Other Observable Inputs
(Level 2)

    

Significant Other Observable Inputs
(Level 3)

Assets:

Cash

$

19,070

$

19,070

$

$

Money market funds

300,672

300,672

Short-term investments:

Commercial paper

3,315

3,315

Corporate debt securities

8,601

8,601

Government securities

19,108

19,108

Total assets

$

350,766

$

338,850

$

11,916

$

There have been no material impairments of our assets measured and carried at fair value as of March 31, 2025 and December 31, 2024. In addition, there have been no changes in valuation techniques as of March 31, 2025 and December 31, 2024. The fair value of Level 1 instruments classified as money market funds and government securities are valued using quoted market prices in active markets. The fair value of Level 2 instruments classified as short-term investments was determined using other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date and fair value is determined using models or other valuation methodologies.  During the three months ended March 31, 2025 and year ended December 31, 2024, there were no transfers between levels.

The short and long-term investments are classified as available-for-sales securities. As of March 31, 2025, the remaining contractual maturities of the available-for-sales securities were 1 to 18 months, the balance in the Company’s accumulated other comprehensive income was comprised of activity related to the Company’s available-for-sale securities. There were no realized gains or losses recognized on the sale or maturity of available-for-sale securities during the three months ended March 31, 2025 and 2024. As a result, the Company did not reclassify any amounts out of accumulated other comprehensive income for the same period. The Company had a limited number of available-for-sale securities in

insignificant loss positions as of March 31, 2025, which the Company does not intend to sell and has concluded will not be required to sell before recovery of amortized cost for the investment maturity.

The following table summarizes the available-for-sale securities (in thousands):

As of March 31, 2025

Amortized Cost

Gross Unrealized Gains

Gross Unrealized Losses

Fair Value

March 31, 2025

Commercial paper

$

6,378

$

9

$

$

6,387

Corporate debt securities

47,228

29

(4)

47,253

Government securities

64,011

13

(4)

64,020

Total

$

117,617

$

51

$

(8)

$

117,660

As of December 31, 2024

Amortized Cost

Gross Unrealized Gains

Gross Unrealized Losses

Fair Value

December 31, 2024

Commercial paper

$

3,311

$

4

$

$

3,315

Corporate debt securities

8,589

12

8,601

Government securities

19,093

17

(2)

19,108

Total

$

30,993

$

33

$

(2)

$

31,024

Certain short-term debt securities with original maturities of less than 90 days are included in cash and cash equivalents on the condensed consolidated balance sheets and are not included in the table above.